{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:30:54Z","timestamp":1744173054527,"version":"3.40.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41390-019-0606-2","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T15:14:36Z","timestamp":1570720476000},"page":"581-587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune recovery following bronchiolitis is linked to a drop in cytokine and LTC4 levels"],"prefix":"10.1038","volume":"87","author":[{"given":"Beatriz","family":"Sastre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luz","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Rodrigo-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"del Pozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"606_CR1","first-page":"60","volume":"24","author":"S Vandini","year":"2017","unstructured":"Vandini, S. et al. Immune and inflammatory response in bronchiolitis due to respiratory syncytial virus and rhinovirus infections in infants. Paediatr. Respir. Rev. 24, 60\u20134 (2017).","journal-title":"Paediatr. Respir. Rev."},{"key":"606_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcv.2018.04.010","volume":"104","author":"EJ Carande","year":"2018","unstructured":"Carande, E. J. et al. Viral bronchiolitis management in hospitals in the UK. J. Clin. Virol. 104, 29\u201333 (2018).","journal-title":"J. Clin. Virol."},{"key":"606_CR3","doi-asserted-by":"publisher","first-page":"e0173504","DOI":"10.1371\/journal.pone.0173504","volume":"12","author":"ML Garc\u00eda-Garc\u00eda","year":"2017","unstructured":"Garc\u00eda-Garc\u00eda, M. L. et al. Human metapnuemovirus infections in hospitalized children and comparison with other respiratory viruses. 2005\u20132014 prospective study. PLoS ONE 12, e0173504 (2017).","journal-title":"PLoS ONE"},{"key":"606_CR4","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1542\/peds.2006-2223","volume":"118","author":"American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis.","year":"2006","unstructured":"American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 118, 1774\u201393 (2006).","journal-title":"Pediatrics"},{"key":"606_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1473-3099(09)70071-4","volume":"9","author":"R Subhi","year":"2009","unstructured":"Subhi, R. et al. The prevalence of hypoxaemia among ill children in developing countries: a systematic review. Lancet Infect. Dis. 9, 219\u201327 (2009).","journal-title":"Lancet Infect. Dis."},{"key":"606_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.chest.2018.04.019","volume":"154","author":"AB Chang","year":"2018","unstructured":"Chang, A. B. et al. Chronic cough related to acute viral bronchiolitis in children: CHEST Expert Panel Report. Chest 154, 378\u201382 (2018).","journal-title":"Chest"},{"key":"606_CR7","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","volume":"134","author":"SL Ralston","year":"2014","unstructured":"Ralston, S. L. et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 134, e1474\u2013502 (2014).","journal-title":"Pediatrics"},{"key":"606_CR8","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1016\/j.vaccine.2016.03.109","volume":"34","author":"D Higgins","year":"2016","unstructured":"Higgins, D., Trujillo, C. & Keech, C. Advances in RSV vaccine research and development\u2014a global agenda. Vaccine 34, 2870\u20135 (2016).","journal-title":"Vaccine"},{"key":"606_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpeds.2016.01.041","volume":"172","author":"JM Mansbach","year":"2016","unstructured":"Mansbach, J. M. et al. Children hospitalized with rhinovirus bronchiolitis have asthma-like characteristics. J. Pediatr. 172, 202\u20134.e1 (2016).","journal-title":"J. Pediatr."},{"key":"606_CR10","doi-asserted-by":"publisher","first-page":"e6787","DOI":"10.1097\/MD.0000000000006787","volume":"96","author":"ML Garc\u00eda-Garc\u00eda","year":"2017","unstructured":"Garc\u00eda-Garc\u00eda, M. L. et al. Thymic stromal lymphopoietin, IL-33, and periostin in hospitalized infants with viral bronchiolitis. Medicine (Baltim.) 96, e6787 (2017).","journal-title":"Medicine (Baltim.)"},{"key":"606_CR11","first-page":"942","volume":"19","author":"P Chomczynski","year":"1995","unstructured":"Chomczynski, P. & Mackey, K. Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 19, 942\u20135 (1995).","journal-title":"Biotechniques"},{"key":"606_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25, 402\u20138 (2001).","journal-title":"Methods"},{"key":"606_CR13","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1128\/JVI.06757-11","volume":"86","author":"I Ioannidis","year":"2012","unstructured":"Ioannidis, I. et al. Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J. Virol. 86, 5422\u201336 (2012).","journal-title":"J. Virol."},{"key":"606_CR14","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1097\/INF.0b013e3182a14407","volume":"32","author":"CM Tabarani","year":"2013","unstructured":"Tabarani, C. M. et al. Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 32, e437\u201342 (2013).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"606_CR15","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1084\/jem.176.6.1489","volume":"176","author":"A Rot","year":"1992","unstructured":"Rot, A. et al. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176, 1489\u201395 (1992).","journal-title":"J. Exp. Med."},{"key":"606_CR16","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1164\/ajrccm.159.6.9805083","volume":"159","author":"AM Harrison","year":"1999","unstructured":"Harrison, A. M. et al. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am. J. Respir. Crit. Care Med. 159, 1918\u201324 (1999).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"606_CR17","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1128\/JVI.80.9.4521-4527.2006","volume":"80","author":"FJ Culley","year":"2006","unstructured":"Culley, F. J. et al. Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J. Virol. 80, 4521\u20137 (2006).","journal-title":"J. Virol."},{"key":"606_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/INF.0b013e31822dc8c1","volume":"31","author":"C Garc\u00eda","year":"2012","unstructured":"Garc\u00eda, C. et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr. Infect. Dis. J. 31, 86\u20139 (2012).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"606_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/infdis\/jiw191","volume":"214","author":"EG Nicholson","year":"2016","unstructured":"Nicholson, E. G. et al. Robust cytokine and chemokine response in nasopharyngeal secretions: association with decreased severity in children with physician diagnosed bronchiolitis. J. Infect. Dis. 214, 649\u201355 (2016).","journal-title":"J. Infect. Dis."},{"key":"606_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.micinf.2012.11.012","volume":"15","author":"MK Lay","year":"2013","unstructured":"Lay, M. K. et al. Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect. 15, 230\u201342 (2013).","journal-title":"Microbes Infect."},{"key":"606_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/QCO.0000000000000159","volume":"28","author":"L Arruvito","year":"2015","unstructured":"Arruvito, L., Raiden, S. & Geffner, J. Host response to respiratory syncytial virus infection. Curr. Opin. Infect. Dis. 28, 259\u201366 (2015).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"606_CR22","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1128\/JVI.79.6.3350-3357.2005","volume":"79","author":"BD Rudd","year":"2005","unstructured":"Rudd, B. D. et al. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 79, 3350\u20137 (2005).","journal-title":"J. Virol."},{"key":"606_CR23","doi-asserted-by":"publisher","first-page":"L202","DOI":"10.1152\/ajplung.00151.2015","volume":"310","author":"A Faksh","year":"2016","unstructured":"Faksh, A. et al. TLR3 activation increases chemokine expression in human fetal airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 310, L202\u201311 (2016).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"606_CR24","doi-asserted-by":"publisher","first-page":"C407","DOI":"10.1152\/ajpcell.00230.2016","volume":"312","author":"Q Zhan","year":"2017","unstructured":"Zhan, Q. et al. Double-stranded RNA upregulates the expression of inflammatory mediators in human aortic valve cells through the TLR3-TRIF-noncanonical NF-\u03baB pathway. Am. J. Physiol. Cell Physiol. 312, C407\u201317 (2017).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"606_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/1099-0496(200008)30:2<166::AID-PPUL15>3.0.CO;2-L","volume":"30","author":"H Bisgaard","year":"2000","unstructured":"Bisgaard, H. Role of leukotrienes in asthma pathophysiology. Pediatr. Pulmonol. 30, 166\u201376 (2000).","journal-title":"Pediatr. Pulmonol."},{"key":"606_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2222.2004.1918.x","volume":"34","author":"D Dimova-Yaneva","year":"2004","unstructured":"Dimova-Yaneva, D. et al. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin. Exp. Allergy 34, 555\u20138 (2004).","journal-title":"Clin. Exp. Allergy"},{"key":"606_CR27","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1203\/00006450-198810000-00018","volume":"24","author":"B Volovitz","year":"1988","unstructured":"Volovitz, B. et al. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr. Res. 24, 504\u20137 (1988).","journal-title":"Pediatr. Res."},{"key":"606_CR28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0091-6749(99)70235-6","volume":"103","author":"SM van Schaik","year":"1999","unstructured":"van Schaik, S. M. et al. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J. Allergy Clin. Immunol. 103, 630\u20136 (1999).","journal-title":"J. Allergy Clin. Immunol."},{"key":"606_CR29","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","volume":"161","author":"N Sigurs","year":"2000","unstructured":"Sigurs, N. et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161, 1501\u20137 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"606_CR30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/thx.2009.121582","volume":"65","author":"N Sigurs","year":"2010","unstructured":"Sigurs, N. et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65, 1045\u201352 (2010).","journal-title":"Thorax"},{"key":"606_CR31","doi-asserted-by":"publisher","first-page":"e0189083","DOI":"10.1371\/journal.pone.0189083","volume":"12","author":"ML Garcia-Garcia","year":"2017","unstructured":"Garcia-Garcia, M. L. et al. Role of viral coinfections in asthma development. PLoS ONE 12, e0189083 (2017).","journal-title":"PLoS ONE"},{"key":"606_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1399-3038.2006.00500.x","volume":"18","author":"L Da Dalt","year":"2007","unstructured":"Da Dalt, L. et al. Nasal lavage leukotrienes in infants with RSV bronchiolitis. Pediatr. Allergy Immunol. 18, 100\u20134 (2007).","journal-title":"Pediatr. Allergy Immunol."},{"key":"606_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1183\/09031936.02.00404602","volume":"20","author":"G Piedimonte","year":"2002","unstructured":"Piedimonte, G. & Simoes, E. A. F. Respiratory syncytial virus and subsequent asthma: one step closer to unravelling the Gordian knot? Eur. Respir. J. 20, 515\u20137 (2002).","journal-title":"Eur. Respir. J."},{"key":"606_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/08035250600554268","volume":"95","author":"CK Kim","year":"2006","unstructured":"Kim, C. K. et al. Increased levels of BAL cysteinyl leukotrienesinacute [corrected] RSV bronchiolitis. Acta Paediatr. 95, 479\u201385 (2006).","journal-title":"Acta Paediatr."},{"key":"606_CR35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.70.5.691","volume":"70","author":"HF Rosenberg","year":"2001","unstructured":"Rosenberg, H. F. & Domachowske, J. B. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J. Leukoc. Biol. 70, 691\u20138 (2001).","journal-title":"J. Leukoc. Biol."},{"key":"606_CR36","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/9550","volume":"5","author":"DW Gilroy","year":"1999","unstructured":"Gilroy, D. W. et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5, 698\u2013701 (1999).","journal-title":"Nat. Med."},{"key":"606_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/mi.2013.71","volume":"7","author":"KA Shirey","year":"2014","unstructured":"Shirey, K. A. et al. Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology. Mucosal Immunol. 7, 549\u201357 (2014).","journal-title":"Mucosal Immunol."},{"key":"606_CR38","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1086\/338570","volume":"185","author":"ML Seymour","year":"2002","unstructured":"Seymour, M. L. et al. Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J. Infect. Dis. 185, 540\u20134 (2002).","journal-title":"J. Infect. Dis."},{"key":"606_CR39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/glia.23276","volume":"66","author":"NM Yousif","year":"2018","unstructured":"Yousif, N. M. et al. Activation of EP2 receptor suppresses poly(I:C) and LPS-mediated inflammation in primary microglia and organotypic hippocampal slice cultures: contributing role for MAPKs. Glia 66, 708\u201324 (2018).","journal-title":"Glia"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0606-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0606-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0606-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:49:25Z","timestamp":1744163365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0606-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0606-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"type":"print","value":"0031-3998"},{"type":"electronic","value":"1530-0447"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"2 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.d.P. has been a consultant\/speaker for AstraZeneca. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}